GemVax&KAEL Co.Ltd (082270) — Capital Reinvestment Ratio
GemVax&KAEL Co.Ltd (082270) has a Capital Reinvestment Ratio of 0.14x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩10.34 Billion) in capital expenditures (₩1.43 Billion). Check GemVax&KAEL Co.Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GemVax&KAEL Co.Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks GemVax&KAEL Co.Ltd's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see 082270 cash flow metrics.
Annual Capital Reinvestment Ratio for GemVax&KAEL Co.Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for GemVax&KAEL Co.Ltd from 2011 to 2025. See cash generation quality of GemVax&KAEL Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.91x | ₩1.11 Billion | ₩2.11 Billion | ▼ -19.6% |
| 2023 | 2.37x | ₩3.57 Billion | ₩8.46 Billion | ▲ +219.2% |
| 2020 | 0.74x | ₩13.95 Billion | ₩10.37 Billion | ▲ +502.4% |
| 2014 | 0.12x | ₩10.64 Billion | ₩1.31 Billion | ▼ -70.9% |
| 2011 | 0.42x | ₩7.42 Billion | ₩3.15 Billion | — |